Smoking Increases Orthopedic Surgery Complications 2.5-Fold: Finnish Study Reveals Critical Preoperative Risk Factor

How Does Smoking Affect Orthopedic Surgery Outcomes?

This interventional study conducted at Päijät-Häme Central Hospital in Finland provides compelling evidence regarding the impact of smoking on complication rates following orthopedic and hand surgery. The research team evaluated 451 patients who underwent bone or cartilage-related surgeries between 2015 and 2019, meticulously tracking complications for 12 months post-surgery. The findings present a clear picture of how smoking behavior influences surgical outcomes in orthopedic patients, with important clinical implications for preoperative counseling and intervention strategies.

The study confirmed that continuing smokers experienced significantly higher complication rates compared to never smokers, with 57.7% of smokers developing at least one complication versus only 30.8% of never smokers. This translated to an average of 0.99 complications per continuing smoker compared to 0.55 per never smoker. After adjusting for confounding factors, the analysis revealed that continuing smokers had 2.5 times higher odds of experiencing at least one complication and 1.58 times higher risk for the number of complications. Perhaps most importantly, complications among smokers were not only more frequent but also more severe, as measured by a modified Clavien-Dindo-Sink classification system, with continuing smokers showing 2.19 times higher odds of experiencing more severe complications compared to never smokers. These findings align with previous research demonstrating smoking's detrimental effects on surgical healing through impaired blood circulation, reduced tissue oxygenation, and compromised immune response.

Could Preoperative Smoking Cessation Change the Game?

A particularly interesting finding was that patients who successfully quit smoking before surgery (though small in number at only 9 individuals) demonstrated complication profiles similar to never smokers, with an average of 0.67 complications per patient. While this subgroup was too small for statistical significance, it suggests the potential benefits of successful preoperative smoking cessation. Additionally, the study identified several other factors independently associated with increased complication risk: younger patient age (contrary to conventional wisdom), female gender, and higher alcohol consumption. The researchers hypothesized that younger patients might have higher expectations for surgical outcomes and thus seek additional healthcare for issues older patients might tolerate, potentially explaining this counterintuitive finding regarding age. Educational level appeared to have a modest protective effect, with higher education correlating with fewer complications.

The study included 451 patients from a target recruitment of 550, with 80 identified as smokers. The mean age of participants was 63.8 years, with smokers being significantly younger (52.8 years) than non-smokers (66.2 years). Demographic analysis revealed that non-smokers consumed less alcohol, had more comorbidities based on the Charlson Comorbidity Index (excluding age), and had a higher prevalence of systemic inflammatory diseases with arthritis compared to smokers. The smoking cessation intervention resulted in 11.3% of smokers quitting before surgery and another 7.5% quitting around the time of surgery. Additionally, 20% of smokers reported reducing their cigarette consumption by approximately 40%.

How Robust is the Study Methodology?

From a methodological perspective, the study had several strengths, including laboratory verification of smoking status through urine cotinine and carboxyhemoglobin testing, a comprehensive 12-month follow-up period, and a broad definition of complications that captured any event requiring additional medical attention. However, the intervention itself achieved only modest success, with just 11.3% of smokers quitting before surgery and 7.5% quitting around the time of surgery. This limited effectiveness likely stemmed from the relatively basic nature of the intervention, which consisted primarily of verbal and written information without providing nicotine replacement therapy or other tangible incentives that have proven effective in other smoking cessation studies. The researchers acknowledged this limitation and noted that more intensive interventions might yield better cessation rates and, consequently, better surgical outcomes.

What are the Clinical and Economic Implications?

For orthopedic surgeons and clinical research professionals, these findings underscore the importance of addressing smoking status as a modifiable risk factor before elective orthopedic procedures. The study suggests that even a modest smoking cessation intervention can benefit some patients, though more comprehensive approaches incorporating pharmacotherapy support would likely prove more effective. The data also highlight the multifactorial nature of surgical risk, with lifestyle factors beyond smoking—particularly alcohol consumption—warranting attention in preoperative assessments. Could more intensive, multicomponent interventions targeting both smoking and alcohol consumption yield even greater reductions in complication rates for orthopedic surgery patients? This represents an important direction for future research.

From a health systems perspective, the study raises important questions about resource allocation for preoperative interventions. Given that complications not only impact patient outcomes but also increase healthcare utilization and costs, what would be the cost-effectiveness of implementing more intensive smoking cessation programs before orthopedic surgery? The potential reduction in complications, particularly severe ones requiring additional interventions or prolonged hospitalization, might offset the initial investment in more comprehensive cessation support. How might healthcare systems best structure these interventions to maximize both patient engagement and clinical benefit? These considerations become particularly relevant in light of growing pressures to improve surgical outcomes while managing healthcare costs.

How Should Future Research Shape Smoking Cessation Strategies?

In conclusion, this Finnish study provides valuable real-world evidence supporting the benefits of smoking cessation before orthopedic surgery. While the intervention itself achieved modest success, the data clearly demonstrate that continued smoking significantly increases both the risk and severity of postoperative complications. For clinical researchers and practitioners, these findings reinforce the importance of addressing smoking as a modifiable risk factor and suggest that more intensive cessation interventions might yield substantial improvements in surgical outcomes. Future research should focus on optimizing preoperative smoking cessation strategies and better understanding how multiple risk factors interact to influence orthopedic surgery complications.

Summary

This interventional study from Päijät-Häme Central Hospital in Finland examined 451 patients who underwent orthopedic and hand surgery between 2015 and 2019, tracking complications for 12 months post-operatively. The research revealed that continuing smokers experienced significantly higher complication rates compared to never smokers, with 57.7% of smokers developing at least one complication versus 30.8% of never smokers. After adjusting for confounding factors, continuing smokers had 2.5 times higher odds of experiencing at least one complication and 2.19 times higher odds of experiencing more severe complications. The study employed laboratory verification of smoking status through urine cotinine and carboxyhemoglobin testing. A notable finding was that patients who successfully quit smoking before surgery demonstrated complication profiles similar to never smokers, though this subgroup was small. The smoking cessation intervention achieved modest success, with 11.3% of smokers quitting before surgery and 7.5% quitting around the time of surgery. Additional risk factors identified included younger patient age, female gender, and higher alcohol consumption. The researchers noted that the intervention's limited effectiveness likely stemmed from its basic nature, consisting primarily of verbal and written information without nicotine replacement therapy or other tangible support mechanisms. The findings underscore the importance of addressing smoking as a modifiable risk factor before elective orthopedic procedures and suggest that more comprehensive, multicomponent interventions incorporating pharmacotherapy support would likely prove more effective in reducing postoperative complications.